Global High-Priority Regulatory Events — April 23, 2026

23-04-2026

AGI Greenpac Limited confirms it is not a 'Large Corporate' as defined under SEBI Master Circular No. SEBI/HO/DDHS/PoD1/P/CIR/2024/54 dated 22nd May 2024 and related circulars, as on 31st March 2026, with outstanding borrowings of ₹205.19 Crore. The company provides its highest credit ratings from CARE Ratings Limited: CARE AA- Stable for Long Term Bank Facilities and CARE A1+ for Short Term Bank Facilities. An initial disclosure in the prescribed format (Annexure-A) has been enclosed for record.

• ·CIN: L51433WB1960PLC024539
• ·ISIN: INE415A01038
• ·BSE Scrip Code: 500187
• ·NSE Symbol: AGI

23-04-2026

The National Company Law Tribunal, Bengaluru Bench, ordered the commencement of the Corporate Insolvency Resolution Process (CIRP) for Vivimed Labs Limited on April 15, 2026 (order received April 17, 2026). T Narayana Swamy (IBBI Regn. No. IBBI/IPA-002/IP-N0 1078/2020-2021/13427) has been appointed as Interim Resolution Professional, with creditors required to submit claims by May 1, 2026. The process is estimated to close by October 11, 2026.

• ·CIN: L02411KA1988PLC009465
• ·Date of incorporation: September 22, 1988
• ·Registered office: Plot No. 78-A, Kolhar Industrial Area, Bidar, Karnataka - 585403
• ·Corporate office: GMR Towers, 3rd & 4th Floor, Green Lands, Begumpet, Beside the Plaza Hotel, Hyderabad, Telangana - 500016
• ·IRP correspondence address: 'VK Commerce', #8, 3rd Floor, 3rd Main Road, Opp. Rajajinagar IT Park, KSSIDC, Rajajinagar Industrial Estate, Bengaluru, Karnataka - 560010; Email: ciq2.vivimedlabslimited@hotmail.com
• ·Notice date: April 20, 2026; Filing date: April 23, 2026

23-04-2026

Deutsche Bank Group, via DB Trustees (Hong Kong) Limited as security agent, disclosed under SEBI (SAST) Regulations 29(1) the creation of an indirect encumbrance over 2,664,580,360 equity shares (8.49% of issued share capital, 8.39% diluted) of Yes Bank Limited held by Verventa Holdings Ltd, effective 17 April 2026, pursuant to a 15 April 2026 facility agreement. This elevates the group's total interest to 2,677,558,246 shares (8.53% issued, 8.43% diluted), while direct voting rights remain unchanged at 12,977,886 shares (0.04%). No actual transfer of shares or change in voting control occurred.

• ·Encumbrance created via share charge dated 15 April 2026 by VML over VHL shares, effective 17 April 2026.
• ·Lenders under facility include Deutsche Bank Aktiengesellschaft, Nomura Singapore Limited, Citibank N.A., London Branch.
• ·Disclosure dated 21 April 2026; additional restrictions on VHL's Yes Bank shares noted separately.
• ·Nomura Singapore Limited independently holds interest in 7,246,300 Yes Bank shares (0.02%) via futures.

23-04-2026

Associated Alcohols & Breweries Limited (AABL) received NCLT Kochi Bench approval on April 16, 2026, for its resolution plan to acquire SDF Industries Ltd., a distillery-cum-bottling unit in Thrissur, Kerala, for ₹30.85 crore, making it a wholly owned subsidiary upon completion. SDF offers IMFL bottling capacity of ~3.60 lakh cases per month and ENA distillery capacity of 75 lacs liters per annum on 10 acres of land, enabling AABL to shift brands like Lemount White Brandy to in-house bottling for improved efficiency. Operations are targeted to commence by September 2026, supporting growth in Kerala where AABL sells ~1.5 lakh cases per month.

• ·SDF facility located on Thrissur-Palakkad border, well-connected to Kochi, Coimbatore, and Calicut airports.
• ·Revised press release corrects IMFL capacity from 'per annum' to 'per month'.
• ·AABL entered Kerala market in 2018, ranking top 3 private players.

23-04-2026

Godavari Biorefineries Limited informed the stock exchanges about newspaper publications in Financial Express (English) and Mumbai Lakshdeep (Marathi) on April 23, 2026, regarding the 'Special Window for Re-lodgement of Transfer Request of Physical Shares' as mandated by SEBI Circular dated January 30, 2026. This disclosure complies with Regulations 30 and 47 of SEBI (LODR) Regulations, 2015. No financial impacts or performance metrics are mentioned.

• ·Script Symbol: GODAVARIB (NSE)
• ·Script Code: 544279 (BSE)
• ·SEBI Circular No.: HO/38/13/11(2)/2026-MIRSD-POD/I/3750/2026

23-04-2026

Future Consumer Ltd disclosed an update on the NCLT (Mumbai) hearing for the insolvency petition filed by State Bank of India, following an earlier disclosure on March 24, 2026. The tribunal granted the company one week to file its reply to the recently served amended Form-1, citing delays by the financial creditor due to year-end audits. The matter has been adjourned to June 4, 2026, with the company committing to further updates.

• ·Counsel for SBI cited delay due to unavailability of bank officials for year closing and audits.
• ·Disclosure in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• ·Scrip Codes: BSE 533400, NSE FCONSUMER

23-04-2026

Jio Financial Services reported robust FY26 growth with Consolidated Total Income (excl. dividends) at ₹3,274 Cr, up 78% YoY, Net Income from Business Operations surging 272% to ₹1,390 Cr, Jio Credit AUM reaching ₹25,700 Cr (2.4x FY25), Payments TPV at ₹52,200 Cr (2.5x FY25), and user base expanding 2.5x to 23 million. However, PPOP (excl. dividends) was nearly flat at ₹1,357 Cr versus ₹1,353 Cr in FY25, impacted by full consolidation of Jio Payments Bank losses post June 2025 acquisition, scaling investments, and treasury yield volatility. Q4 highlights included Total Income over ₹1,000 Cr (+97% YoY), Credit disbursements at ₹10,000 Cr (+49% YoY), and launches like the AI-powered JioFinance app.

• ·Board recommended dividend of ₹0.60 per equity share (face value ₹10).
• ·Jio Payments Bank became 100% subsidiary effective June 18, 2025.
• ·JioBlackRock Asset Management received in-principle approval for retail Fund Management Entity in GIFT City.
• ·Jio Payment Solutions received Payment Aggregator-Cross Border license.
• ·Allianz Jio Reinsurance commenced operations in March 2026.
• ·Jio Insurance Broking POSP agent network across 22 states and 2 Union Territories; Jio Payment Solutions merchant network spans 26 states.

23-04-2026

SERA Investments & Finance India Limited issued a clarification to BSE Ltd. on significant movement in its share price on April 23, 2026. The company stated it has disclosed all material information per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is unaware of any specific reason for the price movement, attributing it solely to market-driven factors. Management confirmed no connection to the share price activity.

• ·Company CIN: L51900GJ1985PLC0110976
• ·Contact: support@serafinances.com, www.serafinances.com
• ·Address: 306 & 307, Ashivwad Paras 1, Opp Andaz Party Plot, Makarba, SG Highway, Ahmedabad, Gujarat - 380051

23-04-2026

Century Plyboards (India) Limited has initiated the second 100 Days Campaign 'Saksham Niveshak' from 1st April 2026 to 9th July 2026, following directives from the Investor Education and Protection Fund Authority (IEPFA), to encourage shareholders to claim unclaimed/unpaid dividends from FY 2018-19 to 2024-25 before transfer to IEPF. The company urges shareholders to update KYC details including PAN, bank account, nomination, and contact information via prescribed forms ISR-1, ISR-2, ISR-3, SH-13, and SH-14 submitted to the RTA. No specific unclaimed dividend amounts are disclosed, and the notice is available on the company's and stock exchanges' websites.

• ·Dividend for FY 2018-19 claimable up to 03.10.2026
• ·RTA address: 23, R. N. Mukherjee Road, 5th Floor, Kolkata – 700001; Phone: 033 2248 2248 / 2243 5029; Email: contact@mdplcorporate.com
• ·Company email for assistance: investors@centuryply.com
• ·Forms downloadable from www.centuryply.com or www.mdpl.in

23-04-2026

On April 22, 2026, the Board of Directors of Netflix, Inc. authorized an additional $25 billion share repurchase program for the company's common stock, with no expiration date, adding to the December 2024 authorization under which approximately $6.8 billion remained available as of March 31, 2026. Repurchases may be conducted via open market transactions compliant with Rule 10b-18, including Rule 10b5-1 trading plans, or other methods, though the company is not obligated to repurchase any specific shares and may discontinue at any time depending on market conditions and other factors.

• ·Repurchases may be effected through open market repurchases, privately-negotiated transactions, accelerated stock repurchase plans, block purchases, or other techniques.
• ·Timing and actual number of shares repurchased will depend on stock price, economic conditions, business factors, and alternative investment opportunities.

23-04-2026

Tesla's Q1 2026 total revenues rose 16% YoY to $22,387 million, fueled by 20% growth in automotive sales to $15,473 million and 42% increase in services to $3,745 million, while gross profit surged 50% to $4,720 million and net income attributable to common stockholders increased 16% to $477 million. However, automotive regulatory credits declined 36% to $380 million, energy generation and storage revenues fell 12% to $2,408 million, automotive leasing dropped 15% to $381 million, and other comprehensive loss was $27 million versus income of $246 million prior year. Operating cash flow strengthened to $3,937 million, but investing cash outflow widened to $5,023 million including a $2,002 million SpaceX equity investment.

• ·Inventory increased 16% QoQ to $14,434 million as of March 31, 2026.
• ·Digital assets decreased to $786 million from $1,008 million QoQ.
• ·Net cash used in investing activities was $5,023 million, up from $1,651 million YoY.
• ·Stock-based compensation expense was $1,093 million in Q1 2026 vs. $662 million in Q1 2025.
• ·Diluted EPS was $0.13 in Q1 2026 vs. $0.12 in Q1 2025.

23-04-2026

Kingsoft Cloud Holdings Ltd's 20-F annual report defines key terms such as 'Premium Customer' and 'Public Cloud Service Premium Customer' as those generating over RMB700,000 in annual revenues. The report highlights risks including dependence on Kingsoft Group and Xiaomi Group for revenues and borrowings, potential limitations on PRC subsidiary dividends, and challenges in acquisition due diligence. A taxation scenario illustrates that hypothetical pre-tax earnings of 100% result in 67.5% net distribution to shareholders after 25% statutory tax and 10% withholding tax.

• ·Net dollar retention rate for Public Cloud Service Premium Customers calculated as revenues from prior-year premium customers in current period divided by revenues from all premium customers in prior period.
• ·Risk of material adverse effect from limitations on PRC subsidiaries' ability to pay dividends (details on page 54).

23-04-2026

Nektar Therapeutics announced the pricing of an upsized $325 million public offering of 3,532,609 shares of common stock at $92.00 per share, with gross proceeds expected to be approximately $325 million before expenses. The company granted underwriters a 30-day option to purchase up to an additional 529,891 shares. Net proceeds will fund general corporate purposes, including research and development, clinical development such as Phase 3 trials for rezpegaldesleukin in atopic dermatitis and alopecia areata, and manufacturing.

• ·Offering expected to close on April 23, 2026, subject to customary conditions.
• ·Underwriters: Jefferies, TD Cowen, and Piper Sandler as joint bookrunning managers; Citigroup as bookrunner.
• ·Pursuant to shelf registration statement on Form S-3ASR (No. 333-291466) filed November 12, 2025.

23-04-2026

Brand Engagement Network Inc. entered into a Securities Purchase Agreement with Ben Capital Fund I, LLC on April 21, 2026, for a private placement of 25,492 shares of common stock at $39.25 per share (120% of the April 21 closing price), yielding gross proceeds of $1,000,561 with 100% warrant coverage; the first installment of $250,101 closed immediately, and the remaining $750,460 is expected before May 29, 2026. Additionally, the Company received $1,114,164 in cash from warrant exercises during April. No declines or flat metrics were reported.

• ·Securities offered and sold pursuant to exemptions from registration requirements of the Securities Act of 1933.
• ·Company qualifies as an emerging growth company.

23-04-2026

Medline Inc. reported strong FY2025 performance with net sales of $28.4 Billion, up 11.5% YoY, organic sales growth of 10.5% YoY, adjusted EBITDA of $3.5 Billion up 3.2% YoY, net cash from operating activities of $1.7 Billion, and free cash flow of $1.3 Billion. However, net income declined 3.6% YoY to $1.2 Billion. The 2026 Proxy Statement seeks election of 12 directors, including CEO James M. Boyle, and advisory approval of executive compensation tied to pay-for-performance.

• ·9 of 12 director nominees are independent.
• ·Sustainability Report released in September 2025, prepared per SASB standards for Medical Equipment and Supplies and Healthcare Distributors.
• ·Two segments: Medline Brand and Supply Chain Solutions.
• ·Over 1,600 active Prime Vendor relationships.

23-04-2026

CenterPoint Energy reported Q1 2026 total revenues of $2,975 million, up approximately 2% YoY from $2,920 million, primarily due to higher utility revenues of $2,960 million versus $2,906 million, while non-utility revenues grew slightly to $15 million from $14 million. Net income rose 6% to $316 million from $297 million, with diluted EPS increasing to $0.48 from $0.45; however, operation and maintenance expenses increased 2% to $766 million from $747 million, and depreciation and amortization surged 17% to $423 million from $363 million. Operating income edged up 1% to $658 million from $649 million amid lower utility natural gas, fuel, and purchased power costs of $970 million versus $1,006 million.

• ·Cash and cash equivalents increased to $639 million from $38 million at December 31, 2025.
• ·Short-term borrowings decreased to $0 from $500 million at December 31, 2025.
• ·VIE Securitization Bonds long-term debt net rose to $1,797 million from $664 million at December 31, 2025.
• ·Property, plant and equipment net increased to $34,262 million from $34,056 million at December 31, 2025.
• ·Weighted average diluted common shares outstanding: 659 million in Q1 2026 vs 653 million in Q1 2025.

23-04-2026

On April 14, 2026, T-REX Acquisition Corp., through its wholly owned subsidiary M M & E 2, LLC, entered into a definitive Asset Purchase Agreement to acquire an operating 3-megawatt turnkey data center located in Roberta, Georgia from Cryptaugh LLC and Sonace LLC. The assets include a 5.8-acre parcel of land, six portable mining containers, and an electrical services contract with Flint Electric Membership Corporation supplying up to 4.5 megawatts of electricity. The transaction is scheduled to close on or before May 25, 2026.

• ·Filing date: April 23, 2026
• ·Filed under Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Exhibit 99.1: Press Release dated April 23, 2026

23-04-2026

Inseego Corp. filed its DEF 14A proxy statement for the Annual Meeting of Stockholders on June 16, 2026, at 10:00 a.m. PT in San Diego, CA, with a record date of April 21, 2026. Stockholders are asked to vote on three proposals: election of two directors (Board recommends FOR all nominees), ratification of CBIZ CPAs P.C. as independent auditors for the fiscal year ending December 31, 2026 (FOR), and an advisory vote to approve named executive officer compensation (FOR). A quorum requires holders of a majority of outstanding common stock present in person or by proxy.

• ·Proxy materials made available electronically on or about May 1, 2026; printed copies available upon request.
• ·Voting methods: in person, telephone, internet, or mail.
• ·Director election uses plurality voting; uncontested nominees must tender resignations if more WITHHOLD than FOR votes per Corporate Governance Guidelines.

23-04-2026

For Q1 2026, Waste Connections reported revenue growth of 6.4% YoY to $2,370,631, driven by strong E&P segment performance (+24.2% to $179,559) and Transfer (+8.3% to $172,748), while Collection rose 5.4% to $1,704,446. However, operating income declined 6.7% YoY to $364,080 due to elevated impairments and other operating items ($79,584 vs $6,440), net income fell 9.2% to $219,344, and Recycling revenues dropped 13.0% to $51,588. Cash from operations remained nearly flat, up 0.8% to $545,598, amid $296,596 in capital expenditures and $283,959 in share repurchases.

• ·Impairments and other operating items increased to $79,584 in Q1 2026 from $6,440 in Q1 2025.
• ·Cash and equivalents rose to $112,447 at March 31, 2026 from $45,968 at Dec 31, 2025.
• ·Long-term debt increased to $9,093,831 at March 31, 2026 from $8,811,104 at Dec 31, 2025.
• ·Shareholders' equity declined to $8,057,619 at March 31, 2026 from $8,245,381 at Dec 31, 2025.
• ·Cash dividends per common share increased to $0.350 from $0.315 YoY.

23-04-2026

Texas Capital Bancshares reported first quarter 2026 net income available to common stockholders of $69.5 million ($1.56 per diluted share), up 63% YoY from $42.7 million but down 28% QoQ from $96.3 million ($2.12 per share), amid higher provisions for credit losses ($16.0 million) and net charge-offs ($17.4 million). The company initiated its first quarterly common stock cash dividend of $0.20 per share and highlighted revenue diversification with non-interest income up 42% YoY to $69.3 million, though net interest income fell 5% QoQ to $254.7 million and efficiency ratio worsened to 65.9%. Capital remains strong with CET1 at 12.0%, total assets grew to $33.5 billion, and book value per share rose 11% YoY to $75.71.

• ·Criticized loans $650.6 million at March 31, 2026, up from $634.9 million at Dec 31, 2025 but down from $762.9 million at March 31, 2025.
• ·Non-accrual LHI $144.9 million (0.58% of total LHI) at March 31, 2026, up from $116.9 million (0.49%) QoQ and $93.6 million (0.42%) YoY.
• ·Allowance for credit losses to total LHI 1.32% at March 31, 2026, down from 1.38% QoQ and 1.48% YoY.
• ·Common stock repurchased at weighted average $96.82 per share.
• ·Preferred dividend $14.375 per share Series B, payable June 15, 2026.

23-04-2026

Indaptus Therapeutics, Inc. appointed Tim Ruan and Dr. Yi Zhang as independent Class II directors effective April 22, 2026, with Mr. Ruan joining the Audit Committee as a financial expert and Dr. Zhang joining the Nominating Committee. Both bring extensive experience in finance/biotech (Ruan from Ocumension Therapeutics, Goldman Sachs, Morgan Stanley) and IP/life sciences (Zhang from JunHe). On the same day, director Matthew McMurdo resigned with no disagreements on company matters.

• ·Appointments decided on April 17, 2026; Director Agreements and Indemnification Agreements executed effective April 22, 2026 (Exhibits 10.1 and 10.2).
• ·Mr. Ruan qualifies as an 'audit committee financial expert' per Item 407(d)(5)(ii) of Regulation S-K.
• ·No arrangements, family relationships, or material interests under Item 404(a) of Regulation S-K for new directors.
• ·Junyi Dai and Qinglai Lu serve as Class III directors (appointed March 18 and April 8, 2026, terms to 2027 annual meeting).

23-04-2026

On April 17, 2026, Idaho Copper Corporation closed a private offering of $1,357,947 in principal amount of convertible promissory notes due in 12 months at an initial conversion price of $6.00 per share, along with warrants to purchase 226,332 shares at $7.50 per share exercisable for 5 years. Of the total, $102,947 in existing notes were converted on a dollar-for-dollar basis by two investors. ThinkEquity LLC served as exclusive placement agent, receiving fees and warrants for 10% of the shares issuable upon note conversion.

• ·Issuance exempt under Section 4(a)(2) and Rule 506(b) of Regulation D to accredited investors only.
• ·Notes bear no interest unless default, then 18% per annum.
• ·Automatic conversion upon national exchange listing at lower of 70% of offering price or $6.00.
• ·Forms filed as Exhibits: 4.1 (Warrant), 10.1 (Subscription Agreement), 10.2 (Note).

23-04-2026

On April 19, 2026, SBC Medical Group Holdings Incorporated entered into an underwriting agreement with Maxim Group LLC for the sale of 3,100,000 shares of its common stock by Dr. Yoshiyuki Aikawa, the CEO and Chairman as selling stockholder; the underwriters received a 45-day option for up to 465,000 additional shares. The offering closed on April 21, 2026, with no shares sold by the Company and no proceeds received by it. This secondary offering was conducted pursuant to a Form S-3 registration statement filed on December 29, 2025.

• ·Underwriting Agreement filed as Exhibit 1.1
• ·Pursuant to Registration Statement on Form S-3 (File No. 333-292451), filed December 29, 2025
• ·Company is an emerging growth company

23-04-2026

Goldman Sachs Private Credit Corp., acting as equityholder and investment advisor, along with borrower GS Private Credit SPV Public I LLC, entered into the Fourth Amendment to the Revolving Credit and Security Agreement on April 17, 2026, with BNP Paribas as administrative agent and lender, and State Street Bank and Trust Company as collateral agent. The amendment modifies the facility originally dated September 28, 2023, following prior amendments on May 30, 2024, October 31, 2024, and January 31, 2025, with changes detailed in Appendix A (not provided). The parties represent no Default or Event of Default exists, and all prior representations and warranties remain true and correct.

• ·Amendment effective upon execution, payment of fees, consents/approvals, and receipt of legal opinion from Dechert LLP.
• ·Governed by New York law.

23-04-2026

Teledyne Technologies Incorporated filed a Restated Certificate of Incorporation on April 23, 2026, restating and amending its original certificate filed on August 23, 1999. The document authorizes 125,000,000 shares of Common Stock and 15,000,000 shares of Preferred Stock, both with a par value of $0.01 per share, and outlines governance provisions including board management authority, indemnification rights, and restrictions on stockholder actions to meetings only. No financial performance metrics or period-over-period changes are reported.

• ·Registered office: 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
• ·Stockholder actions required at meetings; no written consents permitted.
• ·Special meetings callable by Board, Chairman, CEO, or Secretary upon 25% stockholder demand.
• ·Director liability limited except for duty of loyalty breaches, bad faith, etc.

23-04-2026

Coeur Mining, Inc. announced the final results of its exchange offer and consent solicitation for New Gold Inc.'s US$400,000,000 6.875% Senior Notes due 2032, with US$385,800,000 aggregate principal amount (96.45% of outstanding) validly tendered and accepted in exchange for US$385,774,000 in new Coeur 6.875% Senior Notes due 2032 and approximately US$771,600 in cash. The exchange supports integration of New Gold into Coeur's operations, including mines like New Afton, Rainy River, and others. No significant declines noted, with high tender participation indicating strong holder support.

• ·Early Participation Date: April 3, 2026 (5:00 p.m. New York City time)
• ·Expiration Date: April 20, 2026 (5:00 p.m. New York City time)
• ·Settlement Date: April 22, 2026
• ·Exchange Offer Memorandum dated March 23, 2026
• ·Remaining untendered Existing Notes: US$14,200,000 (3.55%)

23-04-2026

On April 21, 2026, the Board of Directors of Capstone Green Energy Holdings, Inc. approved an amendment to the 2023 Equity Incentive Plan, increasing the maximum number of shares of common stock issuable from 4,000,000 to 7,000,000. This change expands the equity pool available for incentives but introduces potential shareholder dilution. The amendment is filed as Exhibit 10.1.

• ·Form 8-K filed on April 23, 2026; event reported as of April 21, 2026; signed April 22, 2026
• ·Common stock trades as CGEH on OTCQX, par value $0.001 per share

23-04-2026

BridgeBio Oncology Therapeutics, Inc. (BBOT) announced the appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman, effective April 20, 2026. Former CEO Eli Wallace, PhD, will transition to Senior Adviser. The changes are positioned to support BBOT's clinical-stage assets entering Phase 1b expansions and combinations in RAS and PI3Kα malignancies.

• ·Announcement date: April 22, 2026
• ·Filing date: April 23, 2026
• ·Dr. Beltran joined BridgeBio Pharma in 2020, became CSO of BBOT in July 2023; prior roles at UNITY Biotechnology and Amgen
• ·BBOT focused on RAS-pathway malignancies with three clinical assets advancing to Phase 1b expansions

23-04-2026

Cuentas Inc. reported zero revenue for the year ended December 31, 2025, a 100% decline from $676 thousand in 2024 across all segments including retail telecommunications ($0 vs $26 thousand), wholesale telecommunication services ($0 vs $569 thousand), and digital products ($0 vs $81 thousand). Net loss improved to $1,571 thousand from $3,309 thousand YoY, with cash and cash equivalents rising to $57 thousand from $15 thousand, but total assets fell to $962 thousand from $1,111 thousand amid ongoing going concern doubts due to liquidity issues and reliance on external funding. Stockholders’ deficit widened to $3,948 thousand from $3,170 thousand, with current liabilities increasing to $4,910 thousand from $4,281 thousand.

• ·Operating expenses slightly improved to $1,894 thousand from $1,918 thousand YoY.
• ·Shares outstanding increased to 4,377,388 from 2,719,668 due to issuance of 1,657,719 shares.
• ·Independent auditor: YAREL + PARTNERS (PCAOB ID No. 1024, Tel Aviv, Israel).
• ·Net cash used in operating activities worsened to $1,371 thousand from $598 thousand.

23-04-2026

For Q1 2026, Goosehead Insurance reported total revenues of $93,076 up 23% YoY from $75,583, driven by 31% growth in commissions and agency fees to $38,685 and 18% growth in franchise revenues to $54,274, leading to operating income of $14,995 (up 127% YoY) and net income attributable to Goosehead of $4,889 (up 109% YoY). However, general and administrative expenses rose 36% YoY to $23,969, cash and cash equivalents declined 25% QoQ to $25,652 from $34,390 primarily due to $49,833 in Class A share repurchases, and total assets decreased to $392,813 from $414,864 at year-end.

• ·Diluted EPS of $0.19 for Q1 2026, up from $0.09 YoY.
• ·Net cash provided by operating activities increased to $22,868 from $15,484 YoY.
• ·Renewal royalty fees of $43,594, up from $37,244 YoY.
• ·Weighted average diluted shares outstanding: 36,640 for Q1 2026 vs 25,943 for Q1 2025.

23-04-2026

PG&E Corporation reported total operating revenues of $6,881 million for the three months ended March 31, 2026, up 15% YoY from $5,983 million, with electric revenues increasing 20% to $4,967 million while natural gas revenues grew 4% to $1,914 million, driving operating income to $1,478 million (+20%) and net income to $954 million (+37%). However, total operating expenses rose 14% to $5,403 million due to a 41% increase in cost of electricity to $561 million and 18% higher operating and maintenance expenses at $3,104 million, and net cash provided by operating activities declined to $2,588 million from $2,955 million.

• ·Wildfire-related claims, net of recoveries: $0 in Q1 2026 (down 100% YoY from $49 million)
• ·Wildfire Fund expense: $102 million in Q1 2026 (up 34% YoY)
• ·Net cash used in investing activities: $(3,302) million in Q1 2026 (increase of $38 million YoY)
• ·Net cash provided by financing activities: $902 million in Q1 2026 (down $673 million YoY)

23-04-2026

ServiceNow reported Q1 2026 total revenues of $3,770 million, up 22% YoY from $3,088 million, with subscription revenues growing 22% to $3,671 million. However, net income increased only 2% to $469 million, income from operations rose 12% to $503 million amid higher operating expenses up 17% to $2,327 million, and operating cash flow was nearly flat at $1,670 million versus $1,677 million. Cash and equivalents declined to $2,702 million from $3,726 million at December 31, 2025, driven by $2,225 million in common stock repurchases and a $1,325 million business combination.

• ·Goodwill increased to $4,541 million from $3,578 million at Dec 31, 2025.
• ·Intangible assets, net rose to $1,479 million from $1,121 million at Dec 31, 2025.
• ·Treasury stock increased to $5,375 million from $3,045 million at Dec 31, 2025 due to repurchases.
• ·Stock-based compensation expense was $547 million in Q1 2026, up from $470 million in Q1 2025.

23-04-2026

Century Communities, Inc. reported total revenues of $789,673 thousand for the three months ended March 31, 2026, down 12.6% YoY from $903,232 thousand, driven by a 16.9% decline in home sales revenues to $734,106 thousand while financial services revenues increased 20.8% to $22,396 thousand. Net income decreased 38.0% YoY to $24,409 thousand ($0.84 diluted EPS) from $39,384 thousand ($1.26 diluted EPS), with most segments showing YoY declines such as Mountain (-28.8%) and West (-13.3%). However, inventories rose 4.9% QoQ to $3,525,742 thousand and total assets increased 1.1% to $4,509,785 thousand.

• ·Net cash used in operating activities increased to $50,321 thousand from $36,580 thousand YoY.
• ·Company repurchased 617 thousand shares for $40,012 thousand and paid dividends of $9,313 thousand during the quarter.
• ·Revolving line of credit balance increased to $203,700 thousand as of March 31, 2026 from $51,500 thousand at December 31, 2025.
• ·Stockholders' equity decreased 1.5% QoQ to $2,553,199 thousand.

23-04-2026

Trane Technologies plc filed its definitive proxy statement for the 2026 Annual General Meeting on June 4, 2026, in Adare, Ireland, seeking shareholder approval for electing 11 directors (10 independent), advisory approval of Named Executive Officer compensation, ratification of PricewaterhouseCoopers LLP as auditors, and renewal of directors' authorities to issue and reallot shares. The Board recommends voting FOR all six proposals, with record date of April 9, 2026. Board composition features diverse expertise in finance, global operations, and technology among nominees.

• ·Record date for voting eligibility: April 9, 2026.
• ·2027 Annual Meeting shareholder proposal deadlines: December 24, 2026 for inclusion in proxy statement; March 6, 2027 for business proposals and director nominations.
• ·April Miller Boise to leave Intel effective June 1, 2026.

23-04-2026

Gentherm reported record Q1 2026 revenue of $394 million, reflecting 7.2% year-over-year growth excluding foreign exchange impacts, alongside expanded gross margins driven by operational initiatives and stronger volumes. The company highlighted progress on its transformational combination with Modine Manufacturing Company's Performance Technologies business (SpinCo), remaining on track to close in 2026.

• ·Conference call scheduled for April 23, 2026 at 8:00 a.m. Eastern Time to discuss Q1 2026 results.
• ·Q1 2026 ended March 31, 2026.

23-04-2026

Amphenol Corporation's open offer to acquire up to 11,96,000 equity shares (26% of voting share capital) of ADC India Communications Limited at INR 1,233.59 per share, sized at INR 147,53,73,640, closed on April 17, 2026, but only 14 shares were tendered and accepted for INR 17,270.26, resulting in negligible post-offer direct shareholding of 0.00%. Public shareholding remained virtually unchanged at 12,86,949 shares (27.98%). Notably, the acquirer had already indirectly acquired 72.02% (33,13,037 shares) via 100% purchase of holding company CST prior to the offer.

• ·Open offer opened on April 2, 2026 and closed on April 17, 2026; payment date April 22, 2026
• ·Equity shares face value: INR 10 each
• ·Pre-offer acquirer direct shareholding: Nil (0.00%)
• ·No shares acquired by agreements or after detailed public statement
• ·Target CIN: L32209KA1988PLC009313; Registered office in Bengaluru

23-04-2026

On April 17, 2026, Clean Energy Technologies, Inc. received a Nasdaq notice for non-compliance with Listing Rule 5250(c)(1) due to failure to file its Form 10-K for the fiscal year ended December 31, 2025. The notice has no immediate effect on trading but requires a compliance plan within 60 days, with potential extension up to October 12, 2026; failure could lead to delisting. Potential delisting risks include reduced liquidity, limited financing access, and impaired employee incentives, with no assurance of regaining compliance.

• ·Nasdaq Listing Rule 5250(c)(1) requires timely filing of periodic reports with SEC
• ·Company has 60 calendar days from April 17, 2026, to submit compliance plan
• ·Nasdaq may grant up to 180 calendar days from 10-K due date (until October 12, 2026) if plan accepted
• ·Appeal opportunity to Nasdaq hearings panel if plan rejected

23-04-2026

Caris Life Sciences, Inc. has issued its 2026 Proxy Statement for the virtual Annual Meeting of Shareholders on June 4, 2026, seeking election of ten director nominees to serve until the 2027 Annual Meeting, with the board size reducing from twelve to ten following the retirement of Drs. George H. Poste and Jonathan Knowles. Shareholders are also asked to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. No financial performance metrics or changes are discussed.

• ·Record Date: Close of business on April 9, 2026
• ·Annual Meeting: Thursday, June 4, 2026, at 10:00 a.m. Central Time, virtual at www.virtualshareholdermeeting.com/CAI2026
• ·Proxy materials sent/disseminated: April 23, 2026
• ·Election requires plurality vote; board not classified (one-year terms)

23-04-2026

IBM's Q1 2026 revenue increased 9% YoY to $15,917 million from $14,541 million, with Sales up 13% to $8,009 million and Services up 6% to $7,688 million, while Net income rose 15% to $1,216 million or $1.28 diluted EPS from $1.12. Gross profit grew 11% to $8,950 million and operating cash flow improved 18% to $5,169 million. However, cash and equivalents fell to $10,819 million from $13,587 million at December 31, 2025, driven by $10,465 million in business acquisitions, with total debt rising to $66,361 million from $61,260 million.

• ·Goodwill increased to $74,709 million from $67,717 million QoQ, reflecting acquisitions.
• ·Total assets grew to $156,229 million from $151,880 million QoQ.
• ·Total liabilities rose to $123,174 million from $119,139 million QoQ.
• ·Dividends paid $1,576 million at $1.68 per share.
• ·Research and development expense up to $2,173 million from $1,950 million YoY.

23-04-2026

So-Young International Inc. reported total revenues of RMB 1,523,410 thousand for the year ended December 31, 2025, up 3.9% YoY from RMB 1,466,698 thousand in 2024, reflecting modest growth. However, the company posted a net loss of RMB 246,905 thousand, an improvement from the RMB 587,182 thousand loss in 2024 but a reversal from the RMB 25,944 thousand net income in 2023, with revenues remaining below 2023 levels of RMB 1,498,029 thousand. Total assets stood at RMB 2,649,636 thousand as of December 31, 2025.

• ·Hypothetical tax scenario assumes 25% statutory rate and 10% withholding tax, resulting in 67.5% net distribution to parent/shareholders.
• ·Preferential tax rates of 15% or 20% available to certain subsidiaries and VIEs but temporary and subject to qualification.
• ·VIE service fees are tax neutral on consolidated basis but filed separately for tax purposes.
• ·Total operating expenses for 2025: RMB 1,013,864 thousand.
• ·Short-term borrowings as of Dec 31 2025: RMB 39,814 thousand.

23-04-2026

Lockheed Martin reported first quarter 2026 sales of $18,021 million, up slightly 0.3% YoY from $17,963 million, but net earnings declined 13% to $1,488 million ($6.44 per share) from $1,712 million ($7.28 per share), with cash from operations dropping sharply to $220 million from $1,409 million and free cash flow turning negative at $(291) million from $955 million. While Missiles and Fire Control sales grew 8% and Space 7%, Aeronautics sales fell 1% and Rotary and Mission Systems 8%, contributing to total business segment operating profit declining 13% to $1,823 million. The company signed multiyear framework agreements to boost munitions production and reaffirmed 2026 guidance for ~5% sales growth to $77,500-$80,000 million and free cash flow of $6,500-$6,800 million.

• ·Q1 2026 business segment operating profit of $1,823 million, down 13% YoY from $2,085 million.
• ·Q1 2026 consolidated operating profit of $2,063 million, down from $2,372 million YoY.
• ·Aeronautics operating margin 8.9% vs 10.2% YoY; Space operating margin 8.2% vs 11.8% YoY.
• ·Q1 2026 independent research and development spend of $458 million.
• ·Effective tax rate 16.1% in Q1 2026 vs 15.9% in Q1 2025.

23-04-2026

Arvana, Inc. entered into a Settlement Agreement on January 13, 2026, with J.P. Carey Enterprises, Inc. to resolve claims totaling $188,379.32 through the issuance of an undetermined number of common stock shares at a 40% discount, plus an additional 250,000 shares for legal fees, approved by court order on April 11, 2026. While this resolves ongoing litigation without cash outlay, it poses significant shareholder dilution risk as the variable share issuance could exceed current outstanding shares and is subject to a 4.99% beneficial ownership limit, requiring multiple tranches.

• ·Settlement Agreement dated January 13, 2026; Court fairness hearing on April 7, 2026; Order entered April 11, 2026.
• ·Litigation: J.P. Carey Enterprises, Inc. v. Arvana, Inc., Case No. CACE-26-000427, Circuit Court of the Seventeenth Judicial Circuit, Broward County, Florida.
• ·Shares issued under Section 3(a)(10) exemption; Company must maintain sufficient authorized shares and avoid impairing stock trading status.

23-04-2026

Restaurant Brands International Inc. (RBI) filed its DEF 14A proxy statement for the 2026 Annual General Meeting on June 3, 2026, seeking shareholder approval to elect ten directors until the 2027 AGM, approve on a non-binding advisory basis the compensation of named executive officers, and appoint KPMG LLP as auditors until the 2027 AGM. The hybrid meeting will be held in person at Tim Hortons headquarters in Toronto or virtually online, with a record date of April 8, 2026. The filing includes XBRL-tagged pay versus performance disclosures for principal executive officers Mr. Cil and Mr. Kobza covering fiscal years 2021 through 2025, but no specific compensation figures are detailed in the provided content.

• ·Record Date: April 8, 2026
• ·Proxy submission deadline: 8:00 a.m. ET on June 2, 2026
• ·Pay vs. performance disclosures cover fiscal years 2021-2025 for PEOs and Non-PEO NEOs

23-04-2026

Baozun Inc.'s 20-F filing presents consolidated balance sheets as of December 31, 2025, showing total assets of RMB 9,691,116 thousand, down 5.1% YoY from RMB 10,207,001 thousand, while total liabilities decreased 5.1% to RMB 4,199,524 thousand. Equity rose 32.2% YoY to RMB 5,433,973 thousand, supported by reduced redeemable non-controlling interests. For FY2025, revenue reached RMB 9,945,483 thousand with operating income of RMB 56,555 thousand, but the company reported a net loss of RMB 199,580 thousand due to RMB 257,318 thousand in other expenses.

• ·Hypothetical taxation scenario assumes maximum statutory 25% EIT plus 10% withholding tax, resulting in 67.5% net available for distribution to parent/shareholders.
• ·Preferential 15% EIT rate for certain subsidiaries is temporary and subject to qualification review; not assumed in hypothetical.
• ·Lower 5% withholding tax possible under tax treaties (e.g., Hong Kong), subject to review.
• ·VIE structure: WFOE service fees to VIE are tax neutral as deductions for VIE and income for WFOE.
• ·Redeemable non-controlling interests: RMB 57,619 thousand as of Dec 31, 2025 (down from RMB 1,670,379 thousand in 2024).

23-04-2026

Shree Ram Twistex Ltd filed an IPO Listing document on April 23, 2026, digitally signed by Ramani Bhaveshbhai Bhikhubhai at 16:14:02 +05'30'. No financial metrics, performance data, or operational details are disclosed in this preliminary filing.

• ·Digital signature timestamp: 2026.04.23 16:14:02 +05'30'

23-04-2026

Helen of Troy Ltd reported FY2026 total net sales revenue of $1,786,290 thousand, down 6.4% YoY from $1,907,665 thousand, driven by organic declines of 12.2% partially offset by 5.6% from acquisitions and 0.3% foreign currency; Home & Outdoor fell 8.1% to $832,870 thousand while Beauty & Wellness declined 4.8% to $953,420 thousand. Gross profit dropped 10.8% to $815,694 thousand amid higher COGS margin, SG&A rose slightly 0.5%, and massive $885,861 thousand asset impairments led to an operating loss of $782,081 thousand and net loss of $898,982 thousand versus prior year's operating income of $142,748 thousand and net income of $123,751 thousand. Adjusted non-GAAP operating income was $148,567 thousand (8.3% margin), down from $252,311 thousand (13.2%), with adjusted EPS of $3.55 versus $7.17.

• ·Organic sales decline: Home & Outdoor -8.6%, Beauty & Wellness -15.6%.
• ·Asset impairments: Home & Outdoor $332,565 thousand (39.9% of sales), Beauty & Wellness $553,296 thousand (58.0%).
• ·Financial covenants: Minimum Interest Coverage 3.00x, Maximum Leverage 4.50x.
• ·GAAP diluted EPS FY2026: $(39.08), FY2025: $5.37; adjusted non-GAAP: $3.55 vs $7.17.
• ·Restructuring charges down 79.7% to $3,005 thousand.

23-04-2026

West Bancorporation Inc reported net income of $10,572 thousand for the three months ended March 31, 2026, up 34.8% YoY from $7,842 thousand, with net interest income increasing 16.9% to $24,385 thousand and noninterest income up 13.9% to $2,554 thousand. However, total assets decreased 3.2% QoQ to $4,010,973 thousand from $4,142,244 thousand, driven by a 23.2% drop in cash and cash equivalents to $361,978 thousand and a $133,498 thousand decline in total deposits to $3,334,972 thousand. Basic EPS improved to $0.62 from $0.47 YoY, while comprehensive income fell to $9,671 thousand from $14,753 thousand due to other comprehensive loss.

• ·Cash dividends declared at $0.25 per common share in both Q1 2026 and Q1 2025.
• ·No credit loss expense in Q1 2026 or Q1 2025.
• ·Net cash used in financing activities $140,261 thousand in Q1 2026 vs $39,668 thousand in Q1 2025.

23-04-2026

Visteon Corporation reported Q1 2026 net sales of $954M, up 2% YoY from $934M, but gross margin declined 18% to $113M from $138M amid higher cost of sales and $18M restructuring charges. Net income attributable to Visteon fell sharply 54% to $31M from $67M, with diluted EPS at $1.14 versus $2.44 YoY, while operating cash flow dropped to $6M from $70M. A small acquisition was completed for $59M total consideration, adding $28M goodwill.

• ·Restructuring expenses of $18M in Q1 2026 (none in Q1 2025).
• ·Share repurchases of $30M in Q1 2026 (vs $7M in Q1 2025).
• ·Dividend to shareholders $10M in Q1 2026.
• ·Small acquisition added $28M goodwill and $37M intangible assets.
• ·Inventories increased to $316M from $269M QoQ.

23-04-2026

Dover Corp reported net earnings of $238,433 for Q1 2026, up 3.3% YoY from $230,821, with operating cash flow rising 21.3% to $190,997. However, comprehensive earnings fell 22.5% YoY to $217,807 due to a $20,626 other comprehensive loss, primarily from foreign currency translation. Total assets grew 0.6% QoQ to $13,506,680, but cash and equivalents declined 2.0% QoQ to $1,641,916.

• ·Dividends paid: $70,446 (Q1 2026)
• ·Common stock repurchased: $53,937 (Q1 2026)
• ·Inventories increased $98,052 QoQ to $1,370,836
• ·Receivables increased $73,206 QoQ to $1,444,558
• ·Net cash used in investing activities: $61,660 (Q1 2026) vs $74,186 (Q1 2025)

23-04-2026

Altisource Portfolio Solutions S.A. reported Q1 2026 revenue of $47,584, up 9.6% YoY from $43,439, reflecting growth in top-line performance. However, gross profit dipped slightly to $13,111 from $13,325 (-1.6% YoY), operating income declined sharply to $1,725 from $3,245 (-46.9% YoY) due to higher SG&A expenses of $11,386 (up from $10,080), and the company recorded a net loss of $635 attributable to Altisource. Positively, the net loss narrowed significantly from $5,344 YoY, and operating cash flow turned positive at $4,453 versus $(4,972) last year.

• ·Long-term debt decreased slightly to $188,526 from $189,861 QoQ.
• ·Accounts payable and accrued expenses increased to $43,725 from $39,595 QoQ.
• ·Weighted average basic shares outstanding: 11,111 (Q1 2026) vs 7,265 (Q1 2025).
• ·Interest paid: $3,128 (Q1 2026) vs $4,535 (Q1 2025).